Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external video platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name Youtube
Purpose External media

Publications

Selected Publications

1.  Lavie M, Struyf S, Stroh-Dege A, Rommelaere J, Van Damme J, Dinsart C. 2013.
Capacity of wild-type and chemokine-armed parvovirus-armed H-1PV for inhibiting tumor angiogenesis. Virology 447:221-32.

2. Halder S, Nam HJ, Govindasamy L, Vogel M, Dinsart C, Salomé N, McKenna R, Agbandje-McKenna M.2013.
Structural characterization of H-1parvovirus: comparison of infectious virions to empty capsids. J.Virol 87,5128-40

3. Sieben M, Schäfer P, Dinsart C, Galle PR, Moehler M. 2013.
Activation oft he human immune system via toll-like receptors by the oncolytic parvovirus H-1. Int J Cancer 132, 2548-56

4. Dempe S, Lavie M, Struyf S, Bhat R, Verbeke H, Paschek S, Berghmans N, Geibig R,   Rommelaere J, Van Damme J, Dinsart C. 2012.
Antitumoral activity of  parvovirus- mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer:  implication of leucocyte recruitment. Cancer Immunol Immunother 61:21113-2123.

5. Weiss N, Stroh-Dege A, Rommelaere J, Dinsart C, Salomé N. 2012.
An in-frame dele- tion in the NS protein-coding sequence of parvovirus H-1PV efficiently stimulates export and infectivity of progeny virions. J Virol 86:7554-7564.

6. Bhat R, Dempe S, Dinsart C, Rommelaere J. 2011.
Enhancement of NK cell anti-tumour responses using an oncolytic parvovirus. Int J Cancer 128:908-919.

7. Dempe S, Stroh-Dege AY, Schwarz E, Rommelaere J, Dinsart C. 2010.
SMAD4: a  pre- dictive marker of PDAC cell permissiveness for oncolytic infection with parvovirus  H-1PV. Int J Canc 126:2914-2927.

to top
powered by webEdition CMS